The implications of pharmacogenomics in the treatment of HIV-1-infected patients of African descent
Hector Clarke, Shaker A MousaThe Pharmaceutical Research Institute, Albany College of Pharmacy and Health Sciences, Rensselaer, NY, USAAbstract: One of the great advances in the treatment of HIV-1 infection was the development of the highly active antiretroviral therapy (HAART). Although this treatm...
Main Authors: | Hector Clarke, Shaker A Mousa |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2009-09-01
|
Series: | Pharmacogenomics and Personalized Medicine |
Online Access: | http://www.dovepress.com/the-implications-of-pharmacogenomics-in-the-treatment-of-hiv-1-infecte-a3533 |
Similar Items
-
Pharmacogenomics in cardiovascular disorders: Steps in approaching personalized medicine in cardiovascular medicine
by: Christopher Barone, et al.
Published: (2009-09-01) -
Pharmacogenomics and pharmacokinetics of antiretroviral drugs and their associations with metabolic complications in HIV-infected Black South Africans
by: Sinxadi, Phumla Z
Published: (2016) -
Pharmacogenomics in type II diabetes mellitus management: Steps toward personalized medicine
by: Peter Avery, et al.
Published: (2009-09-01) -
A European Spectrum of Pharmacogenomic Biomarkers: Implications for Clinical Pharmacogenomics.
by: Clint Mizzi, et al.
Published: (2016-01-01) -
The cardiovascular profile of HIV–infected South Africans of African descent : a 5–year prospective study / Botha S.
by: Botha, Shani
Published: (2012)